← All diseases
Infectious diseases
Chronic hepatitis C
Do you want to receive a message when new research on Chronic hepatitis C is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, every publication shows one sentence explaining what was studied — and you'll receive a notification as soon as new research on Chronic hepatitis C is available. View what Premium costs.
Publications and studies (1942)
- Direct-acting antiviral treatment significantly shaped the gut microbiota in chronic hepatitis C patients: a pilot study. (2025/09/04) ♡
- Impact of Chronic Hepatitis C Virus on Acute Kidney Injury After Living Donor Liver Transplantation. (2025/09/01) ♡
- [Antiviral treatment for chronic viral hepatitis B and C in children in Ostrava]. (2025/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement. (2025/09/01) ♡
- Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings. (2025/09/01) ♡
- Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies. (2025/08/29) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. [A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C]. (2025/06/20) ♡
- Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C. (2025/06/17) ♡
- Real-life data of hepatitis C treatment with direct acting antiviral therapy in persons injecting drugs or on opioid substitution therapy. (2025/06/01) ♡
- Implementation of Glecaprevir-Pibrentasvir for Children Aged 3-12 Years With Chronic Hepatitis C: Multicentre Israeli Experience. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of chronic hepatitis C infection: strategies to address poor therapy adherence. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era. (2025/05/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sofosbuvir Therapy and IFNL4 Genotype. (2025/05/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pediatric and Adolescent Hepatitis C Care Cascade and Real-World Treatment Outcomes Utilizing an Integrated Health System Specialty Pharmacy Model. (2025/05/13) ♡
- lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C. (2025/05/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bullous Pemphigoid Overlapping Psoriasis Vulgaris: A Rare Case Report and Literature Review. (2025/05/08) ♡
- Health-related Quality of Life in Children and Adolescents After Successful Treatment of Chronic Hepatitis C With Sofosbuvir/Velpatasvir: One-year Outcomes. (2025/05/01) ♡
- Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines. (2025/04/29) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of Direct-Acting Antiviral Therapy on All-Cause Mortality in Chronic Hepatitis C Patients. (2025/04/01) ♡
- Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment. (2025/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study. (2025/04/01) ♡
- Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort. (2025/04/01) ♡
- Challenges and Opportunities for Treating Hepatitis C Amongst People Who Use Drugs: Experience of an Integrated Mobile Clinic in Baltimore City. (2025/04/01) ♡
- Real-World Effectiveness of All-Oral Direct-Acting Antivirals in Patients With Hepatitis C Virus-Related HCC. (2025/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study. (2025/04/01) ♡
- Global Burden of Major Chronic Liver Diseases in 2021. (2025/04/01) ♡
- Elucidating the multi-target pharmacological mechanism of Xiaoyandina for the treatment of hepatitis C virus based on bioinformatics and cyberpharmacology studies. (2025/03/14) ♡
- Changes in liver stiffness and steatosis in children after successful treatment with sofosbuvir/velpatasvir: Results of the PANDAA-PED study. (2025/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct-Acting Antivirals Induce Lymphoproliferative Disease Response in HCV-Infected Patients With Indolent B-Cell Non-Hodgkin's Lymphoma: A Prospective Observational Study. (2025/03/01) ♡
- Outcomes of liver transplantation with donors older than 80 years in HCV patients treated with direct-action antivirals vs. non-HCV patients. (2025/02/28) ♡
- Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study. (2025/02/24) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis. (2025/02/12) ♡
- Impact of Sustained Virological Response on Long-Term Outcomes After Curative Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Therapy. (2025/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Current management and awareness of hepatitis coinfection in HIV care: A single-center retrospective study in Japan. (2025/02/01) ♡
- Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy. (2025/02/01) ♡
- Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA. (2025/02/01) ♡
- Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals. (2025/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of complete remission by cabozantinib as an end-line treatment for advanced hepatocellular carcinoma. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Host-targeting antivirals for chronic viral infections of the liver. (2025/02/01) ♡
- Effect of depressive symptoms on health services utilization in the HIV and hepatitis C co-infected population in Canada. (2025/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure. (2025/02/01) ♡
- Attitudes and perspectives of healthcare workers on treating chronic hepatitis C infection in children and adolescents. (2025/01/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute kidney injury and ANCA positivity in a patient treated with glecaprevir/pibrentasvir: a case report. (2025/01/15) ♡
- Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma. (2025/01/07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study. (2025/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Strategy for early detection of viral hepatitis in patients with a request for liver biochemistry profile and hypertransaminasemia. (2025/01/01) ♡
- Heterogeneous development of liver fibrosis in chronic hepatitis C patients; assessment by extracellular volume fraction map generated from routine clinical CT data. (2025/01/01) ♡
- UPLC Estimate of Sofosbuvir and Ledipasvir Utilizing Greenness Tool in Conjunction With an Analytical Quality by Design. (2025/01/01) ♡
- HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals. (2025/01/01) ♡
- Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment. (2025/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.